MOLNAR Z et al. Enhancement of NMDA responses by ß-amyloid peptides in the hippocampus in vivo. (2004) NEUROREPORT 0959-4965 15 1649-1652,
247687
Szakcikk (Folyóiratcikk) | Tudományos[247687]
Biasetti Luca et al. Elevated amyloid beta disrupts the nanoscale organization and function of synaptic vesicle pools in hippocampal neurons. (2022) CEREBRAL CORTEX 1047-3211 1460-2199
Ahnaou A. et al. Sleep, neuronal hyperexcitability, inflammation and neurodegeneration: does early chronic short sleep trigger and is it the key to overcoming Alzheimer's disease?. (2021) NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 0149-7634 1873-7528 129 157-179
Manap Aimi Syamima et al. Explicating anti-amyloidogenic role of curcumin and piperine via amyloid beta (A beta) explicit pathway: recovery and reversal paradigm effects. (2020) PEERJ 2167-8359 8
Varela Eva Vico et al. Excitatory-inhibitory imbalance in Alzheimer's disease and therapeutic significance. (2019) NEUROBIOLOGY OF DISEASE 0969-9961 1095-953X 127 605-615
Marsh Jade et al. Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention. (2018) NEURAL REGENERATION RESEARCH 1673-5374 1876-7958 13 4 616-623
Lei Ming et al. Soluble A beta oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance. (2016) NEUROBIOLOGY OF DISEASE 0969-9961 1095-953X 85 111-121
Zhou F et al. MLK3-MKK3/6-P38MAPK cascades following N-methyl-D-aspartate receptor activation contributes to amyloid-beta peptide-induced apoptosis in SH-SY5Y cells. (2014) JOURNAL OF NEUROSCIENCE RESEARCH 0360-4012 1097-4547 92 6 808-817
Tucci P et al. Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats. (2014) FRONTIERS IN BEHAVIORAL NEUROSCIENCE 1662-5153 1662-5153 8 p. 332
Tucci P et al. Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats. (2014) FRONTIERS IN BEHAVIORAL NEUROSCIENCE 1662-5153 1662-5153 8
Annweiler C et al. Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. (2014) NEUROBIOLOGY OF AGING: AGE-RELATED PHENOMENA NEURODEGENERATION AND NEUROPATHOLOGY 0197-4580 1558-1497 35 2 331-335
Danaei F et al. Alzheimer's disease can cause epileptic seizure activity in a CA3-CA1 tripartite synapse: A computational study. (2014) Megjelent: 22nd Iranian Conference on Electrical Engineering, ICEE 2014 pp. 1996-1999
Riascos D et al. Alterations of Ca< sup> 2+-responsive proteins within cholinergic neurons in aging and Alzheimer's disease. (2014) NEUROBIOLOGY OF AGING: AGE-RELATED PHENOMENA NEURODEGENERATION AND NEUROPATHOLOGY 0197-4580 1558-1497 35 6 1325-1333
Behensky AA et al. Afobazole Activation of sigma-1 Receptors Modulates Neuronal Responses to Amyloid-beta(25-35). (2013) JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 0022-3565 1521-0103 347 2 468-477
Dong XH et al. Osthole improves synaptic plasticity in the hippocampus and cognitive function of Alzheimer's disease rats via regulating glutamate. (2012) NEURAL REGENERATION RESEARCH 1673-5374 1876-7958 7 30 2325-2332
Olivares David et al. N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer's Disease, Vascular Dementia and Parkinson's Disease. (2012) CURRENT ALZHEIMER RESEARCH 1567-2050 1875-5828 9 6 746-758
Miguel-Hidalgo JJ et al. Memantine prevents cognitive impairment and reduces Bcl-2 and caspase 8 immunoreactivity in rats injected with amyloid beta(1-40). (2012) EUROPEAN JOURNAL OF PHARMACOLOGY 0014-2999 1879-0712 692 1-3 38-45
Babri S et al. Effect of aggregated β-amyloid (1-42) on synaptic plasticity of hippocampal dentate gyrus granule cells in Vivo. (2012) BIOIMPACTS 2228-5652 2228-5660 2 4 189-194
Kapai NA et al. Donepezil in a narrow concentration range augments control and impaired by beta-amyloid peptide hippocampal LTP in NMDAR-independent manner. (2012) CELLULAR AND MOLECULAR NEUROBIOLOGY 0272-4340 1573-6830 32 2 219-226
Mezler M et al. A β-amyloid oligomer directly modulates P/Q-type calcium currents in Xenopus oocytes. (2012) BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 165 5 1572-1583
Russell CL et al. Amyloid-beta Acts as a Regulator of Neurotransmitter Release Disrupting the Interaction between Synaptophysin and VAMP2. (2012) PLOS ONE 1932-6203 1932-6203 7 8
Danysz W et al. Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine – searching for the connections. (2012) BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 167 2 324-352
Nyakas C et al. The basal forebrain cholinergic system in aging and dementia.: Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. (2011) BEHAVIOURAL BRAIN RESEARCH 0166-4328 1872-7549 221 2 594-603
Li S et al. Soluble a β oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. (2011) JOURNAL OF NEUROSCIENCE 0270-6474 1529-2401 31 18 6627-6638
Klyubin I et al. Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine. (2011) NEUROBIOLOGY OF AGING: AGE-RELATED PHENOMENA NEURODEGENERATION AND NEUROPATHOLOGY 0197-4580 1558-1497 32 4 614-623
Corona C et al. New therapeutic targets in Alzheimer's disease: Brain deregulation of calcium and zinc. (2011) CELL DEATH AND DISEASE 2041-4889 2041-4889 2 6
Itkin A et al. Calcium Ions Promote Formation of Amyloid beta-Peptide (1-40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease. (2011) PLOS ONE 1932-6203 1932-6203 6 3
Randall AD et al. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. (2010) NEUROPHARMACOLOGY 0028-3908 1873-7064 59 4-5 243-267
Granic I et al. Calpain inhibition prevents amyloid-β-induced neurodegeneration and associated behavioral dysfunction in rats. (2010) NEUROPHARMACOLOGY 0028-3908 1873-7064 59 4-5 334-342
Wei W et al. Amyloid beta from axons and dendrites reduces local spine number and plasticity. (2010) NATURE NEUROSCIENCE 1097-6256 1546-1726 13 2 190-196
Bergin DH et al. Agmatine protects against β-amyloid 25-35-induced memory impairments in the rat. (2010) NEUROSCIENCE 0306-4522 1873-7544 169 2 794-811
Li SM et al. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. (2009) NEURON 0896-6273 1097-4199 62 6 788-801
Akan P et al. Pregnenolone protects the PC-12 cell line against amyloid beta peptide toxicity but its sulfate ester does not. (2009) CHEMICO-BIOLOGICAL INTERACTIONS 0009-2797 177 1 65-70
Balleza-Tapia H et al. Pharmacology of the Intracellular Pathways Activated by Amyloid Beta Protein. (2009) MINI-REVIEWS IN MEDICINAL CHEMISTRY 1389-5575 1875-5607 9 6 724-740
Yamin G. NMDA receptor-dependent signaling pathways that underlie amyloid β-protein disruption of LTP in the hippocampus. (2009) JOURNAL OF NEUROSCIENCE RESEARCH 0360-4012 1097-4547 87 8 1729-1736
Hu NW et al. GluN2B subunit-containing NMDA receptor antagonists prevent A beta-mediated synaptic plasticity disruption in vivo. (2009) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 0027-8424 1091-6490 106 48 20504-20509
Abbott JJ et al. A beta(1-42) modulation of Akt phosphorylation via alpha 7 nAChR and NMDA receptors. (2008) NEUROBIOLOGY OF AGING: AGE-RELATED PHENOMENA NEURODEGENERATION AND NEUROPATHOLOGY 0197-4580 1558-1497 29 7 992-1001
Cai G-L et al. Serum excitatory amino acids concentrations in patients with amnestic mild cognitive impairment or Alzheimer's disease. (2007) ZHONGHUA SHEN JING KE ZA ZHI / CHINESE JOURNAL OF NEUROLOGY 1006-7876 40 8 544-548
Troulinaki K et al. Neurodegenerative conditions associated with ageing: a molecular interplay?. (2005) MECHANISMS OF AGEING AND DEVELOPMENT 0047-6374 1872-6216 126 23-33
Szegedi V et al. Divergent effects of A beta 1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo. (2005) BRAIN RESEARCH 0006-8993 1872-6240 1062 120-126,
1047152
Szakcikk (Folyóiratcikk) | Tudományos[1047152]
Yang Han et al. A Novel Targeted and High-Efficiency Nanosystem for Combinational Therapy for Alzheimer's Disease. (2020) ADVANCED SCIENCE 2198-3844
Caioli Silvia et al. Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease. (2017) NEUROPHARMACOLOGY 0028-3908 1873-7064 116 82-97
Farbood Y et al. Peripheral and central administration of T3 improved the histological changes, memory and the dentate gyrus electrophysiological activity in an animal model of Alzheimer’s disease. (2017) METABOLIC BRAIN DISEASE 0885-7490 1573-7365 32 3 693-701
Wang Qiang et al. Determination of the levels of two types of neurotransmitter and the anti-migraine effects of different dose-ratios of Ligusticum chuanxiong and Gastrodia elata. (2016) JOURNAL OF FOOD AND DRUG ANALYSIS 1021-9498 1021-9498 24 1 189-198
Shabani Sahreh et al. Central and peripheral administrations of levothyroxine improved memory performance and amplified brain electrical activity in the rat model of Alzheimer's disease. (2016) NEUROPEPTIDES 0143-4179 1532-2785 59 111-116
Ali Tahir et al. Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus. (2015) SCIENTIFIC REPORTS 2045-2322 5
Wang Qiang et al. Effects of Ligusticum chuanxiong and Gastrodia elata on blood-brain barrier permeability in migraine rats. (2015) PHARMAZIE 0031-7144 0031-7144 70 6 421-426
Chen Peng-zhi et al. Gastrodin Suppresses the Amyloid beta-Induced Increase of Spontaneous Discharge in the Entorhinal Cortex of Rats. (2014) NEURAL PLASTICITY 2090-5904 1687-5443 2014
Noroozian Maryam et al. Early-Onset Alzheimer's Disease in Two Iranian Families: A Genetic Study. (2014) DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 1420-8008 1421-9824 38 5-6 330-336
Parsons Chris G et al. Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease. (2013) NEUROTOXICITY RESEARCH 1029-8428 1476-3524 24 3 358-369
Danysz W et al. Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine – searching for the connections. (2012) BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 167 2 324-352
Minano-Molina AJ et al. Soluble Oligomers of Amyloid-beta Peptide Disrupt Membrane Trafficking of alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Contributing to Early Synapse Dysfunction. (2011) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 286 31 27311-27321
Klyubin I et al. Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine. (2011) NEUROBIOLOGY OF AGING: AGE-RELATED PHENOMENA NEURODEGENERATION AND NEUROPATHOLOGY 0197-4580 1558-1497 32 4 614-623
McMillan LE et al. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model. (2011) NEUROSCIENCE LETTERS 0304-3940 1872-7972 502 3 201-208
Proctor DT et al. Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease. (2011) PROGRESS IN NEUROBIOLOGY: AN INTERNATIONAL REVIEW JOURNAL 0301-0082 1873-5118 93 4 509-521
Randall AD et al. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. (2010) NEUROPHARMACOLOGY 0028-3908 1873-7064 59 4-5 243-267
Renner M et al. Deleterious Effects of Amyloid beta Oligomers Acting as an Extracellular Scaffold for mGluR5. (2010) NEURON 0896-6273 1097-4199 66 5 739-754
Alberdi E et al. Amyloid beta oligomers induce Ca(2+) dysregulation and neuronal death through activation of ionotropic glutamate receptors. (2010) CELL CALCIUM 0143-4160 1532-1991 47 3 264-272
Hu NW et al. GluN2B subunit-containing NMDA receptor antagonists prevent A beta-mediated synaptic plasticity disruption in vivo. (2009) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 0027-8424 1091-6490 106 48 20504-20509
Sun MK. The quest for treatment of cognitive impairment: AMPA and mGlu5 receptor modulators. (2008) EXPERT OPINION ON THERAPEUTIC PATENTS 1354-3776 18 9 999-1010
Parameshwaran K et al. Amyloid beta-peptide A beta(1-42) but not A beta(1-40) attenuates synaptic AMPA receptor function. (2007) SYNAPSE 0887-4476 1098-2396 61 6 367-374
Pena F et al. The role of beta-amyloid protein in synaptic function: Implications for Alzheimer's disease therapy. (2006) CURRENT NEUROPHARMACOLOGY 1570-159X 1875-6190 4 2 149-163
Szegedi V et al. Pentapeptides derived from A beta 1-42 protect modulatory effect of A beta fibrils - an in vivo electrophysiological study. (2005) NEUROBIOLOGY OF DISEASE 0969-9961 1095-953X 18 3 499-508,
1008631
Szakcikk (Folyóiratcikk) | Tudományos[1008631]
Perlikowska R.. Whether short peptides are good candidates for future neuroprotective therapeutics?. (2021) PEPTIDES 0196-9781 1873-5169 140
Eslami M et al. Chronic ghrelin administration restores hippocampal long-term potentiation and ameliorates memory impairment in rat model of Alzheimer's disease. (2018) HIPPOCAMPUS 1050-9631 1098-1063 28 10 724-734
Rahimi F et al. Modulators of Amyloid β-Protein (Aβ) Self-Assembly. (2016) Megjelent: Developing Therapeutics for Alzheimer's Disease: Progress and Challenges pp. 97-191
Li Huiyuan et al. Modulation of Amyloid beta-Protein (A beta) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting A beta Toxicity. (2016) ACS CHEMICAL NEUROSCIENCE 1948-7193 1948-7193 7 7 845-856
Shabani Sahreh et al. Central and peripheral administrations of levothyroxine improved memory performance and amplified brain electrical activity in the rat model of Alzheimer's disease. (2016) NEUROPEPTIDES 0143-4179 1532-2785 59 111-116
Rocha S. Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer's Disease. (2013) CURRENT PHARMACEUTICAL DESIGN 1381-6128 1873-4286 19 37 6635-6646
Lo Adrian C et al. Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active A beta toxicity inhibitor SEN1500. (2013) NEUROPHARMACOLOGY 0028-3908 1873-7064 75 458-466
Willbold D et al. A survey of peptides with effective therapeutic potential in Alzheimer's disease rodent models or in human clinical studies. (2012) MINI-REVIEWS IN MEDICINAL CHEMISTRY 1389-5575 1875-5607 12 5 388-398
Li HY et al. C-Terminal Tetrapeptides Inhibit A beta 42-Induced Neurotoxicity Primarily through Specific Interaction at the N-Terminus of A beta 42. (2011) JOURNAL OF MEDICINAL CHEMISTRY 0022-2623 1520-4804 54 24 8451-8460
Randall AD et al. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. (2010) NEUROPHARMACOLOGY 0028-3908 1873-7064 59 4-5 243-267
Janusz M et al. Colostral Proline-Rich Polypeptides - Immunoregulatory Properties and Prospects of Therapeutic Use in Alzheimer's Disease. (2010) CURRENT ALZHEIMER RESEARCH 1567-2050 1875-5828 7 4 323-333
Maji SK et al. Amino Acid Position-specific Contributions to Amyloid beta-Protein Oligomerization. (2009) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 284 35 23580-23591
Masters CL. Future directions: the Abeta amyloid pathway as the target for diadnosing, preventing, or treating Alzheimer's disease. (2007) Megjelent: Neurobiology of Alzheimer's Disease pp. 413-438
Masman M. Model peptides for binding studies on peptide-peptide interactions: The case of Amyloid beta(1-42) Aggregates. (2006) Megjelent: Model peptides for binding studies on peptide-peptide interactions: The case of Amyloid beta(1-42) Aggregates p. 1
Estrada LD et al. Inhibition of protein misfolding and aggregation by small rationally-designed peptides. (2006) CURRENT PHARMACEUTICAL DESIGN 1381-6128 1873-4286 12 20 2557-2567
Szegedi V et al. Transient alterations in neuronal and behavioral activity following bensultap and fipronil treatment in rats. (2005) TOXICOLOGY 0300-483X 1879-3185 214 1-2 67-76,
1143511
Szakcikk (Folyóiratcikk) | Tudományos[1143511]
Colmano Nicolas et al. Effects of Fipronil and surface behavior of neuronal insect and mammalian membranes. (2022) BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 0005-2736 1879-2642 1864 10
Song Xiao et al. Toxic effects of fipronil and its metabolites on PC12 cell metabolism. (2021) ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 0147-6513 1090-2414 224 p. 112677
Soualah Zineb et al. GABAA Receptor Subunit Composition Drives Its Sensitivity to the Insecticide Fipronil. (2021) FRONTIERS IN NEUROSCIENCE 1662-4548 1662-453X 15
